GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (STU:OJU1) » Definitions » Cyclically Adjusted Book per Share

Oramed Pharmaceuticals (STU:OJU1) Cyclically Adjusted Book per Share : €2.60 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Oramed Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Oramed Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2025 was €3.189. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.60 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Oramed Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 5.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 18.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Oramed Pharmaceuticals was 21.50% per year. The lowest was 8.30% per year. And the median was 18.20% per year.

As of today (2025-05-27), Oramed Pharmaceuticals's current stock price is €1.878. Oramed Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €2.60. Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.72.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oramed Pharmaceuticals was 16.95. The lowest was 0.70. And the median was 3.18.


Oramed Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Oramed Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals Cyclically Adjusted Book per Share Chart

Oramed Pharmaceuticals Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.20 1.36 2.09 2.37 2.55

Oramed Pharmaceuticals Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 2.66 2.48 2.55 2.60

Competitive Comparison of Oramed Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Oramed Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oramed Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.189/134.9266*134.9266
=3.189

Current CPI (Mar. 2025) = 134.9266.

Oramed Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201505 1.761 100.333 2.368
201508 1.928 100.548 2.587
201511 1.811 100.135 2.440
201602 2.250 100.040 3.035
201605 2.086 101.355 2.777
201608 1.772 101.617 2.353
201611 1.676 101.829 2.221
201702 1.506 102.779 1.977
201705 1.346 103.256 1.759
201708 1.192 103.587 1.553
201711 1.354 104.072 1.755
201802 1.152 105.052 1.480
201805 0.974 106.148 1.238
201808 1.551 106.383 1.967
201811 1.461 106.338 1.854
201902 1.285 106.649 1.626
201905 1.109 108.048 1.385
201908 1.003 108.245 1.250
201911 0.892 108.519 1.109
202002 0.639 109.139 0.790
202005 1.344 108.175 1.676
202008 1.173 109.662 1.443
202011 1.002 109.793 1.231
202102 1.445 110.968 1.757
202105 1.837 113.576 2.182
202108 2.788 115.421 3.259
202111 3.914 117.269 4.503
202203 3.823 121.301 4.252
202206 3.770 125.017 4.069
202209 3.972 125.227 4.280
202212 3.622 125.222 3.903
202303 3.528 127.348 3.738
202306 3.478 128.729 3.645
202309 3.469 129.860 3.604
202312 3.724 129.419 3.882
202403 3.784 131.776 3.874
202406 4.049 132.554 4.121
202409 3.505 133.029 3.555
202412 3.499 133.157 3.545
202503 3.189 134.927 3.189

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Oramed Pharmaceuticals  (STU:OJU1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.878/2.60
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oramed Pharmaceuticals was 16.95. The lowest was 0.70. And the median was 3.18.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Oramed Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Oramed Pharmaceuticals Business Description

Traded in Other Exchanges
Address
1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Oramed Pharmaceuticals Headlines

No Headlines